✦ LIBER ✦

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer

✍ Scribed by Renee M. Gerrero, Steven Stein, Dr Edward A. Stadtmauer

Book ID: 120807114
Publisher: Springer International Publishing AG
Year: 2002
Tongue: English
Weight: 158 KB
Volume: 19
Category: Article
ISSN: 1170-229X
DOI: 10.2165/00002512-200219070-00001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer

✍ Lois J. Ayash 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

94 P - Paclitaxel containing high-dose c

94 P - Paclitaxel containing high-dose chemotherapy and autologous blood stem cell support for high risk primary breast cancer

✍ H.T. Greinix; W. Linkeach; M. Seifert; E. Kubista; K. Czerwendka; S.A. Brugger; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 180 KB

1124 Evaluation of pathological response

1124 Evaluation of pathological response for breast cancer after high dose chemotherapy (HDC) and autologous stem cell support

✍ Gravis, G.; Jacquemier, J.; Blaise, D.; Cowen, D.; Houvenaeghel, G.; Camerlo, J. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Stem Cell Dose and Tumorbiologic Paramet

Stem Cell Dose and Tumorbiologic Parameters as Prognostic Markers for Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy with Autologous Blood Stem Cell Support

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Martin Ko 📂 Article 📅 2002 🏛 AlphaMed Press 🌐 English ⚖ 121 KB

The psychosocial experience of women tre

The psychosocial experience of women treated for breast cancer by high-dose chemotherapy supported by autologous stem cell transplant: a qualitative analysis of support groups

✍ R. Feigin; A. Greenberg; H. Ras; Y. Hardan; S. Rizel; T. Ben Efraim; S.M. Stemme 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Autologous bone marrow transplantation (AuBMT) is probably among the most aggressive of physical treatments endured by cancer patients. High-risk breast cancer patients who choose this therapy face prolonged, agonizing and life-threatening interventions that are no less arduous than confronting the

High-dose chemotherapy and autologous st

High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy

✍ deMagalhaes-Silverman, M; Hammert, L; Lembersky, B; Lister, J; Rybka, W; Ball, E 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 48 KB